Status of initiative: N/a
Description/achievement of initiative

GSK commits to increases support for the WHO strategy to improve children’s health with a new 5-year commitment to expand donations of albendazole medicine to 1 billion doses each year, an increase of 600 million doses each year. This increased donation in collaboration with WHO hopes to create universal access to de-worming forall school age children in Africa.

Implementation methodologies

By supporting the WHO's strategy to improve children's health and expanding donations of albendazole medicine.

Arrangements for Capacity-Building and Technology Transfer

Coordination mechanisms/governance structure

Partner(s)

Deliverables
2015
GSK commits to increases support for the WHO strategy to improve children’s health with a new 5-year commitment to expand donations of albendazole medicine to 1 billion doses each year, an increase of 600 million doses each year.
Sustainable Development Goals and targets
Goal 5
Resources devoted to implementation
In-kind contribution
expand donations of albendazole medicine to 1 billion doses each yea
SMART
This initiative does not yet fulfil the SMART criteria.
SDGs
Action Network
Information
Location: Global
Date of completion: 2015
Operating in countries
Partner connections
Contact information/focal point(s)
,

Documents
#SDGAction1224
Terms of use | Privacy Notice | Copyright © United Nations 2016